Assessing the breast cancer risk distribution for women undergoing screening in British Columbia

Cancer Prevention Research

Volumn 6, Issue 10, 2013, Pages 1084-1092

  Weisstock, Christina R ^a   Rajapakshe, Rasika ^a   Bitgood, Christabelle ^b   McAvoy, Steven ^a   Gordon, Paula B ^c   Coldman, Andrew J ^a   Parker, Brent A ^a   Wilson, Christine ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ETHNIC DIFFERENCE; FEMALE; GROUPS BY AGE; HEALTH SURVEY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MEDICAL DECISION MAKING; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CANCER; PATIENT REFERRAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BREAST; BREAST NEOPLASMS; BRITISH COLUMBIA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MIDDLE AGED; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84888066836     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-13-0027     Document Type: Article

References (43)

1. Screening Mammography Program of British Columbia. Screening Mammography Program 2011 annual report. BC Cancer Agency. 2011:1-58.
2. Singletary S. Rating the risk factors for breast cancer. Ann Surg 2003;237:474-82. (Pubitemid 38176426)
3. Santen R, Boyd N, Chlebowski R, Cummings S, Cuzick J, Dowsett M, et al. Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model. Endocr Relat Cancer 2007;14:169-87. (Pubitemid 47242621)
4. Nelson H, Zakher B, Cantor A, Fu R, Griffin J, O'Meara E, et al. Risk factors for breast cancer for women aged 40 to 49 years. Ann Intern Med 2012;156:635-48.
5. Tyrer J, Duffy S, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004;23:1111-30. (Pubitemid 38477070)
6. Gail M, Brinton L, Byar D, Corle D, Green S, Schairer C, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 1989;81:1879-86. (Pubitemid 20026073)
7. Claus E, Risch N, Thompson W. Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 1991;48:232-42. (Pubitemid 21891587)
8. Ford D, Easton D, Bishop D, Narod S, Goldgar D, the Breast Cancer Linkage Consortium. Risks of cancer in BRCA1-mutation carriers. Lancet. 1994;343:692-5. (Pubitemid 24087847)
9. Antoniou A, Pharoah P, Smith P, Easton D. The BOADICEA model of genetic susceptibility to breast and ovarian cancer. Br J Cancer 2004;91:1580-90. (Pubitemid 39486366)
10. Parmigiani G, Berry D, Aguilar O. Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2. Am J Hum Genet 1998;62:145-58. (Pubitemid 28093844)
11. Amir E, Freedman O, Seruga B, Evans D. Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 2010;102:680-91.
12. Quante A, Whittemore A, Shriver T, Strauch K, Terry M. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance. Breast Cancer Res 2012;14:R144.
13. Saslow D, Boetes C, Burke W, Harms S, Leach M, Lehman C, et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89. (Pubitemid 46535708)
14. National Institute for Health and Care Excellence (2013) Clinical guideline 164: Classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer. CG164. London: National Institute for Health and Care Excellence. 2013:1-57.
15. Cancerview.ca [Internet]. Breast cancer screening in Canada: key components for breast cancer screening programs/strategies across Canada [updated 2013 Apr 17, 2013; cited 2013 Jul 15, 2013]. Available from: www.cancerview.ca/cv/portal/Home/PreventionAndScreening/ PSProfessionals/ PSScreeningAndEarlyDiagnosis/BreastCancerScreening?-afrLoop = 240433351374000&-afrWindowMode = 0&-adf.ctrl-state = 19frlqkbi6-4.
16. Berg W, Zhang Z, Lehrer D, Jong R, Pisano E, Barr R, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. J Am Med Assoc 2012;307:1394-404.
17. Kuhl C, Weigel S, Schrading S, Arand B, Bieling H, Konig R, et al. Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial. J Clin Oncol 2010;28:1450-7.
18. Warner E, Messersmith H, Causer P, Eisen A, Shumak R, Plewes D. Systematic review: Using magnetic resonance imaging to screen women at high risk for breast cancer. Ann Intern Med 2008;148:671-9. (Pubitemid 351669112)
19. Granader E, Dwamena B, Carlos R. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach. Acad Radiol 2008;15:1590-5.
20. Elmore J, Barton M, Moceri V, Polk S, Arena P, Fletcher S. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med 1998;338:1089-96. (Pubitemid 28227478)
21. McCann J, Stockton D, Godward S. Impact of false-positive mammography on subsequent screening attendance and risk of cancer. Breast Cancer Res 2002;4:R11.
22. Graubard B, Freedman A, Gail M. Five-year and lifetime risk of breast cancer among U.S. subpopulations: implications for magnetic resonance imaging screening. Cancer Epidemiol Biomarkers Prev 2010;19:2430-6.
23. Evans D, Warwick J, Astley S, Stavrinos P, Sahin S, Ingham S, et al. Assessing individual breast cancer risk within the U.K. National Health Service breast screening program: a new paradigm for cancer prevention. Cancer Prev Res 2012;5:943-51.
24. Seyednoori T, Pakseresht S, Roushan Z. Risk of developing breast cancer by utilizing Gail model. Women Health 2012;52:391-402.
25. Brinton J, Barke L, Freivogel M, Jackson S, O'Donnell C, Glueck D. Breast cancer risk assessment in 64,659 women at a single high-volume mammography clinic. Acad Radiol 2012;19:95-9.
26. Breast Cancer Risk Assessment Project [Internet]. c2013 [updated 2012; cited 2013 Jul 15]. Available from: www.breastcancerrisk.ca.
27. IBIS Breast Cancer Risk Evaluation Tool [Internet] [updated 2013 June 20; cited 2013 Jul 15]. Available from: www.ems-trials.org/riskevaluator.
28. Breast Cancer Risk Assessment Tool [Internet] [updated 2011 May 16; cited 2013 Jul 15] Available from: www.cancer.gov/bcrisktool/Default.aspx.
29. Breast Cancer Risk Assessment Macro [Internet] [updated Dec 2012; cited 2013 Jul 15] Available from: dceg.cancer.gov/tools/risk-assessment/bcrasasmacro.
30. Statistics Canada [Internet]. Population by selected ethnic origins, by province and territory (2006 Census); [updated 2009 Jul 28; cited 2013 Jul 15]. Available from: www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo26k-eng. htm.
31. Gail M, Mai P. Comparing breast cancer risk assessment models. J Natl Cancer Inst 2010;102:665-8.
32. Statistics Canada [Internet]. Population and dwelling counts, for Canada, provinces and territories, census metropolitan areas and census agglomerations, 2001 and 1996 Censuses [updated 2001; cited 2013 Jul 15]. Available from: www12.statcan.ca/english/census01/products/standard/popdwell/Table-CMA-P.cfm?T= 1&SR=1&PR=59&S=3&O=D.
33. Phillips N, Coldman A. Comparison of nonbreast cancer incidence, survival and mortality between breast screening program participants and nonparticipants. Int J Cancer 2008;122:197-201. (Pubitemid 350209996)
34. Katapodi M, Lee K, Facione N, Dodd M. Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 2004;38:388-402. (Pubitemid 38327011)
35. Ward E, Smith R. Integrating tools for breast cancer risk assessment, risk reduction, and early detection. Cancer Epidemiol Biomarkers Prev 2010;19:2428-9.
36. Evans D, Howell A. Breast cancer risk-assessment models. Breast Cancer Res 2007;9:213-20.
37. McPherson K, Steel C, Dixon J. Breast cancer - epidemiology, risk factors, and genetics. Br Med J 2000;321:624-8.
38. BC Cancer Agency [Internet]. Hereditary Cancer Program. c2012 [Updated 2013 May 22; cited 2013 July 15]. Available from: www.screeningbc.ca/Hereditary/ GetReferral/Default.htm.
39. BC Stats [Internet]. Population by age and sex: B.C. and other provincial and territorial populations: 1971-2012 (July 1); c2013 [updated January 2013; cited 2013 Jul 15]. Available from: www.bcstats.gov.bc.ca/StatisticsBySubject/ Demography/PopulationEstimates.aspx.
40. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe H, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 2006;56:168-83. (Pubitemid 43847927)
41. Berg W, Blume J, Cormack J, Mendelson E, Lehrer D, Bohm-Velez M, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. J Am Med Assoc 2008;299:2151-63. (Pubitemid 351679706)
42. Berg W, Blume J, Adams A, Jong R, Barr R, Lehrer D, et al. Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology 2010;254:79-87.
43. Cott C, Lee J, Gilmore M, Kong C, Lowry K, Halpern E, et al. Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers. Cancer 2012;119:1266-76.